Drug search by name
Bontril Slow-Release and Canakinumab Subcutaneous
Determining the interaction of Bontril Slow-Release and Canakinumab Subcutaneous and the possibility of their joint administration.
Check result:
Bontril Slow-Release <> Canakinumab Subcutaneous
Relevance: 16.08.2023
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Bontril Slow-Release
Generic Name: phendimetrazine
Brand name: Bontril, Melfiat, Bontril PDM
Synonyms: Bontril
Canakinumab Subcutaneous
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Bontril Slow-Release-Canasa
- Bontril Slow-Release-Canasa Pac rectal
- Bontril Slow-Release-Canasa rectal
- Bontril Slow-Release-Cancidas
- Bontril Slow-Release-Candesartan
- Bontril Slow-Release-Candesartan and Hydrochlorothiazide
- Canakinumab Subcutaneous-Bontril Slow-Release Capsules
- Canakinumab Subcutaneous-Boostrix
- Canakinumab Subcutaneous-Boostrix Intramuscular
- Canakinumab Subcutaneous-Boroleum
- Canakinumab Subcutaneous-Bortezomib
- Canakinumab Subcutaneous-Bortezomib Intravenous
Doktika World
Interaction with food and lifestyle
Disease interaction